carvedilol has been researched along with myricetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bulic, B; Mandelkow, E; Pickhardt, M | 1 |
| Choi, JS; Lee, W; Woo, ER | 1 |
1 review(s) available for carvedilol and myricetin
| Article | Year |
|---|---|
Progress and developments in tau aggregation inhibitors for Alzheimer disease.
Topics: Alzheimer Disease; Animals; Clinical Trials as Topic; Humans; Hydrogen Bonding; Models, Molecular; Protein Binding; Protein Conformation; Structure-Activity Relationship; tau Proteins | 2013 |
1 other study(ies) available for carvedilol and myricetin
| Article | Year |
|---|---|
Effects of myricetin on the bioavailability of carvedilol in rats.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Carbazoles; Carvedilol; Cell Line, Tumor; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Enzyme Inhibitors; Flavonoids; Fluorescent Dyes; Humans; Injections, Intravenous; Intestine, Small; Liver; Male; Propanolamines; Rats; Rats, Sprague-Dawley; Rhodamine 123 | 2012 |